28.05.2025
Artem Shendetskii
News Author and Editor
28.05.2025

SEC advances review of WisdomTree XRP spot ETF proposal

SEC advances review of WisdomTree XRP spot ETF proposal SEC reviews WisdomTree XRP ETF, public input sought

​In a notable regulatory development, the U.S. Securities and Exchange Commission (SEC) has advanced its review of WisdomTree’s proposed XRP spot exchange-traded fund (ETF). 

The ETF, submitted through the Cboe BZX Exchange, is now in the next phase of the SEC’s vetting process, which includes soliciting public comments on critical matters such as market impact, investor protection, and manipulation risks.

While the agency has not yet made a final decision, the move signals a heightened level of scrutiny and interest in the proposal—marking a step closer to potentially approving the first-ever U.S.-based XRP spot ETF. The SEC’s notice, published under Release No. 34-103124, opens a 240-day window to approve or reject the application, as stipulated under Section 19(b)(2)(B) of the Securities Exchange Act of 1934.

Ripple lawsuit resolution strengthens regulatory clarity

This regulatory shift comes after a letter to the SEC from Stuart Alderoti. Ripple's CLO sent a letter calling on the SEC to address gaps in the regulation of cryptocurrency-based investment products.

This legal progress, combined with the launch of XRP futures ETF contracts on the CME, has emboldened market confidence and set the stage for spot product approvals. The SEC is now expected to perform a deeper analysis of WisdomTree’s proposal, evaluating its structure, risk profile, and legal compliance.

While no ETF has yet been approved, the SEC’s active engagement with WisdomTree’s application signals growing momentum toward regulatory acceptance. The outcome of this process could pave the way not only for XRP but for a broader class of crypto-based ETFs in U.S. markets.

We wrote earlier that XRP ETF approval hopes grow despite SEC hurdles.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.